NASDAQ:VIRI
Virios Therapeutics, Inc.
- Stock
Last Close
0.39
17/05 20:00
Market Cap
7.90M
Beta: 1.93
Volume Today
509.03K
Avg: 2.87M
PE Ratio
−1.08
PFCF: −1.11
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -2.11M - | -2.47M 17.03% | -10.35M 318.27% | -15.96M 54.26% | -12.25M 23.26% | -5.30M 56.76% | |
depreciation and amortization | 53.98K - | ||||||
deferred income tax | -53.98K - | ||||||
stock based compensation | 7.43M - | 322.88K 95.65% | 582.66K 80.46% | 619.97K 6.40% | |||
change in working capital | 869.13K - | 316.48K 63.59% | -974.06K 407.78% | -52.19K 94.64% | 197.38K 478.18% | -194.45K 198.51% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | 65.64K - | -89.82K 236.85% | 51.56K 157.40% | 270.01K 423.68% | 219.30K 18.78% | -461.25K 310.33% | |
other working capital | 803.49K - | 406.30K 49.43% | -1.03M 352.43% | -322.20K 68.59% | -21.92K 93.20% | 266.81K 1,317.01% | |
other non cash items | 48.51K - | 65.00K 34.01% | -4.26K 106.55% | ||||
net cash provided by operating activities | -1.20M - | -2.09M 74.94% | -3.90M 86.18% | -15.69M 302.79% | -11.47M 26.91% | -4.87M 57.53% | |
investments in property plant and equipment | |||||||
acquisitions net | |||||||
purchases of investments | |||||||
sales maturities of investments | |||||||
other investing activites | |||||||
net cash used for investing activites | |||||||
debt repayment | -2.37M - | -1.93M 18.58% | |||||
common stock issued | 31.35M - | -97.60K 100.31% | 4.49M 4,700.84% | 1.16M 74.25% | |||
common stock repurchased | -1.86M - | -295.17K 84.10% | |||||
dividends paid | -75K - | ||||||
other financing activites | 1.15M - | 4.74M 312.27% | 5.89M 24.26% | 295.17K 94.99% | |||
net cash used provided by financing activities | 1.15M - | 2.37M 106.13% | 33.38M 1,307.59% | -97.60K 100.29% | 4.49M 4,700.84% | 1.16M 74.25% | |
effect of forex changes on cash | |||||||
net change in cash | -45.49K - | 279.36K 714.15% | 29.49M 10,454.91% | -15.79M 153.54% | -6.98M 55.80% | -3.71M 46.77% | |
cash at beginning of period | 75.51K - | 30.03K 60.24% | 309.38K 930.39% | 29.80M 9,530.55% | 14.01M 52.99% | 7.03M 49.81% | |
cash at end of period | 30.03K - | 309.38K 930.39% | 29.80M 9,530.55% | 14.01M 52.99% | 7.03M 49.81% | 3.32M 52.82% | |
operating cash flow | -1.20M - | -2.09M 74.94% | -3.90M 86.18% | -15.69M 302.79% | -11.47M 26.91% | -4.87M 57.53% | |
capital expenditure | |||||||
free cash flow | -1.20M - | -2.09M 74.94% | -3.90M 86.18% | -15.69M 302.79% | -11.47M 26.91% | -4.87M 57.53% |
All numbers in USD (except ratios and percentages)